Cutaneous T-Cell Lymphoma (CTCL) Emerging and Marketed Drugs Assessment According to DelveInsight’s evaluation, globally, more than 25 key...

Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...

Researchers aimed to detect autoantibodies against TA-MUC1, a key indicator of pancreatic cancer. Early pancreatic cancer detection could be a game...

Optiscan has signed a Memorandum of Understanding (MOU) with University of Minnesota College of Veterinary Medicine to trial clinical applications ...

BRISBANE, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing...

The exports of drugs and pharmaceuticals from India are experiencing consistent growth, reflecting an increase of 8.36 percent to reach (Dollor)...

The landscape of ovarian cancer treatment is evolving, driven by the growing role of genetic markers and personalized medicine, informs Dr. Vamsi...

A study of fasting and the ketogenic diet reveals a new vulnerability of pancreatic tumors to an existing cancer drug.

Amplia’s pancreatic cancer drug shows progress. HitIQ secures a second US patent for mouthguard technology. ...